Pharmabiz

Ripan Mehta takes helm as Haryana’s new drug controller, vows ‘Zero Tolerance’ and industry mentorship

Ripan Mehta takes helm as Haryana’s new drug controller, vows ‘Zero Tolerance’ and industry mentorship: Our Bureau, Chennai ...
Pharmabiz

Ollin Biosciences announces final data from randomized head-to-head study of OLN324 compared to faricimab in wAMD and diabetic macular edema

Ollin Biosciences announces final data from randomized head-to-head study of OLN324 compared to faricimab in wAMD and diabetic macular edema: Austin, Texas Wednesday, April 1, 202 ...
Pharmabiz

Centrum rolls out ‘Har Din Ko Kar Recharge’ campaign encouraging a nutritious way to beat everyday tiredness

Centrum rolls out ‘Har Din Ko Kar Recharge’ campaign encouraging a nutritious way to beat everyday tiredness: Our Bureau, ...
Pharmabiz

US FDA clears Abbisko Therapeutics' IND application for FGFR2/3 inhibitor, ABSK061 for achondroplasia in children

US FDA clears Abbisko Therapeutics' IND application for FGFR2/3 inhibitor, ABSK061 for achondroplasia in children: Shanghai Wednesday, April 1, 2026, 15:00 Hrs [IST] Abbisko Thera ...
Pharmabiz

Haemonetics receives US FDA nod to expand labelling of VASCADE MVP XL venous vascular closure system

Haemonetics receives US FDA nod to expand labelling of VASCADE MVP XL venous vascular closure system: Boston Wednesday, April 1, 2026, 17:00 Hrs [IST] Haemonetics Corporation, a g ...
Pharmabiz

Authorities audit 49 businesses as part of monitoring supply chain of GLP-1 drugs, says centre

Authorities audit 49 businesses as part of monitoring supply chain of GLP-1 drugs, says centre: Our Bureau, New Delhi Wednesday, April 1, 2026, 14:15 Hrs [IST] The authorities hav ...
Pharmabiz

Mom’s Belief to deepen access to neurodevelopmental care across India

Mom’s Belief, an early intervention and neurodevelopmental care provider, has announced plans to expand its footprint across India with the launch of new centres that actively position parents as ...
Pharmabiz

Cancer Vaccine Coalition commits $1 million grant for phase II study at University of Texas for tests to detect cellular evidence of cancer

Cancer Vaccine Coalition commits $1 million grant for phase II study at University of Texas for tests to detect cellular evidence of cancer: Houston Wednesday, April 1, 2026, 16:0 ...
Pharmabiz

European Commission grants conditional marketing authorisation to Sanofi’s Rezurock to treat chronic graft-vs-host disease

European Commission grants conditional marketing authorisation to Sanofi’s Rezurock to treat chronic graft-vs-host disease: Paris Wednesday, April 1, 2026, 11:00 Hrs [IST] The E ...
Pharmabiz

Bristol Myers Squibb evolves and expands Standing in the Gaap to advance more equitable care in multiple myeloma as programme marks ten years

Bristol Myers Squibb evolves and expands Standing in the Gaap to advance more equitable care in multiple myeloma as programme marks ten years: Princeton, New Jersey Wednesday, Apr ...
Pharmabiz

Rusan Healthcare unveils APOSAN 3ml multi-dose pen

Rusan Healthcare Pvt. Ltd., the marketing and distribution arm of Rusan Pharma Limited, an integrated global pharmaceutical ...
Pharmabiz

GHIT Fund and TSRI sign MoU to strengthen partnership through co-funding initiative

GHIT Fund and TSRI sign MoU to strengthen partnership through co-funding initiative: Tokyo, Japan Wednesday, April 1, 2026, 13:00 Hrs [IST] The Global Health Innovative Technology ...